Advanced Search
MENG Fankai, TAN Xiyou, LI Chunrui, HUANG Lifang, LIU Wenli, ZHOU Jianfeng, SUN Hanying. Molecular Cloning and Function Analysis of Human Cyclin D3 Gene Promoter Region in A2780 Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 9-12. DOI: 10.3971/j.issn.1000-8578.2014.01.003
Citation: MENG Fankai, TAN Xiyou, LI Chunrui, HUANG Lifang, LIU Wenli, ZHOU Jianfeng, SUN Hanying. Molecular Cloning and Function Analysis of Human Cyclin D3 Gene Promoter Region in A2780 Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 9-12. DOI: 10.3971/j.issn.1000-8578.2014.01.003

Molecular Cloning and Function Analysis of Human Cyclin D3 Gene Promoter Region in A2780 Cells

More Information
  • Received Date: January 12, 2013
  • Revised Date: April 02, 2013
  • Objective To analyze the structure and function of human Cyclin D3 promoter. Methods Cyclin D3 promoter sequences were amplified by PCR method and the PCR products were inserted into pGL3-Basic vectors to construct the Cyclin D3 promoter-pGL3-Basic vectors (pD3-Δ). The pD3-Δ plasmids were transiently transfected into A2780 cells with the liposome. The promoter activities of pD3-Δ were detected by dual luciferase reporter assay to screen the key area of transcription and regulation. The regulation regions were assayed by TFSEARCH 1.3v to presume the key transcription factors. Results Cyclin D3 promoter sequences with different length were amplifi ed successfully by PCR and the cyclin D3 promoter-pGL3-Basic vectors(pD3-Δ)were well constructed. The dual luciferase reporter assay results implicated two positive (-1044bp to -766bp, -362bp to -197bp) and one negative (-766bp to -551bp) regulatory sequences located in Cyclin D3 promoter. TFSEARCH displayed that binding motifs of some transcription factors, such as C/EBP, SP1, AP1, HSF and MZF1, were contained in the regions. Conclusion Cyclin D3 promoter sequences have two positive (-1044bp to -766bp, -362bp to -197bp) and one negative (-766bp to -551bp) regulatory sequences which contain binding motifs of some transcription factors, such as C/EBP, SP1, AP1, HSF and MZF1, etc., and these transcription factors could regulate the promoter activity through binding motifs in A2780 cells.
  • [1]
    Rosen DG, Yang G, Liu G, et al. Ovarian cancer: pathology, biology, and disease models [J]. Front Biosci, 2009, 14:2089-102.
    [2]
    Zhang SW,Chen WQ,Wei W,et al.Ovary cancer mortality in China 20 04-2005: results from the third national retrospective sampling survey of death causes[J].Zhonghua Yu Fang Yi Xue Za Zhi, 20 10,44(5):418-22.[张思维,陈万青,魏文,等.中国第三次死因抽 样调查(2004-2005)卵巢癌死亡情况分析[J].中华预防医学杂 志,2010,44(5):418-22.]
    [3]
    Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression[J]. Genes Dev, 1999, 13 (12):1501-12.
    [4]
    Blain SW. Switching cyclin D-Cdk4 kinase activity on and off [J]. Cell Cycle, 2008, 7(7):892-8.
    [5]
    Masamha CP, Benbrook DM. Cyclin D1 degradation is suffi cient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells[J]. Cancer Res, 2009, 69 (16):6565-72.
    [6]
    Wang Z,Zhang Y,Lu J,et al.Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor[J]. Blood, 1999, 93(12):4208-21.
    [7]
    Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control[J]. Trends Cell Biol, 2007, 17(7):318-24.
    [8]
    Vesely PW, Staber PB, Hoefl er G, et al. Translational regulation mechanisms of AP-1 proteins [J]. Mutat Res, 2009, 682(1):7-12.
    [9]
    Lecomte S, Desmots F, Le Masson F, et al. Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability[J]. Oncogene, 2010, 29(29):4216-24.
    [10]
    Mudduluru G, Vajkoczy P, Allgayer H. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer [J]. Mol Cancer Res, 2010, 8( 2):159-69.
    [11]
    Previdi S, Malek A, Albertini V, et al. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts[J]. Gynecol Oncol, 2010, 118(2):182-8.
  • Related Articles

    [1]Chen QIN, Pei-yuan QIU, Qian-han DENG, Li LI. LIPG expression in ovarian cancer is associated with platinum resistance and prognosis[J]. Cancer Research on Prevention and Treatment. DOI: 10.3971/j.issn.1000-8578.2026.25.0430
    [2]YANG Danni, ZHAO Mengna, FENG Xiaoye, TONG Jiyu, WANG Hua, CAI Hongbing. Value of Inflammatory Load in Predicting Prognosis of Elderly Patients with Epithelial Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 361-367. DOI: 10.3971/j.issn.1000-8578.2024.23.1174
    [3]TAN Fangchun, LI Li. Review of Molecular Subtyping of Ovarian Cancer and Its Clinical Application[J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771
    [4]ZHENG Haiyan, RUAN Jian, PAN Linglan, LIU Jianqiao. Cathepsin L Promotes Invasion and Migration of Human Ovarian Cancer Cell Line SKOV3[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 556-559. DOI: 10.3971/j.issn.1000-8578.2015.06.005
    [5]FAN Bei, LI Hongxia, WU Yumei, ZHAO Qun, DENG Xiaohong. Biological Characteristics of Paclitaxel-resistance Ovarian Cancer Cell Lines and Cryopreservation Methods[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 334-339. DOI: 10.3971/j.issn.1000-8578.2015.04.004
    [6]ZHONG Yanping, MENG Yongzhen, LI Li, YIN Fuqiang, LI Danrong, ZHANG Wei. Biological Characteristics of Side Population Cells in Ovarian Cancer Cell Line SKOV3[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1282-1285. DOI: 10.3971/j.issn.1000-8578.2014.12.006
    [7]YANG Zongyuan, SUN Chaoyang, ZHOU Bo, LI Na, HE Yang, DING Dong, CHEN Gang, ZHU Tao. MicroRNA-107 Targeting Dicer1 for Metastasis Control in Ovarian Cancer Cell Lines[J]. Cancer Research on Prevention and Treatment, 2013, 40(07): 660-666. DOI: 10.3971/j.issn.1000-8578.2013.07.008
    [8]TIAN Xun, WANG Wei, XING Hui, XU Qian, LI Fu-jun, LU Yun-ping, WANG Shi-xuan, MA Ding. Molecular Mechanism of Apoptosis in Cisplatin-resistant Human Ovarian Cancer Cell Line Promoted by Topotecan[J]. Cancer Research on Prevention and Treatment, 2005, 32(06): 360-363. DOI: 10.3971/j.issn.1000-8578.646
    [9]DENG An-mei, ZHONG Ren-qian, CHEN Sun-xiao, et al, . United detection of tumor markers in patients with ovarian cancer with protein chip[J]. Cancer Research on Prevention and Treatment, 2002, 29(06): 475-476. DOI: 10.3971/j.issn.1000-8578.1290
    [10]Dong Yuelan, Li Lin, Chen Lixin. The Relatonship Between the Expression of P16 in Ovarian Cancer and Clinical Stages[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 109-110.

Catalog

    Corresponding author: SUN Hanying, tjhxyk@163.com

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2094) PDF downloads (1007) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return